The biology of aging: The current research agenda

Cancer

Volumn 80, Issue 7, 1997, Pages 1284-1293

  Ershler, William B ^a,b   Longo, Dan L ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Cancer and aging; Free radicals; Immune senescence; Immunosurveillance; Telomeres; Theories of aging

Indexed keywords

AGE; AGING; CARCINOGENESIS; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; REVIEW; SENESCENCE;

AGING; ANIMALS; BIOLOGICAL MARKERS; CELL AGING; GERIATRICS; HUMANS; LONGEVITY; NEOPLASMS; RESEARCH;

EID: 0030922887     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971001)80:7<1284::AID-CNCR14>3.0.CO;2-3     Document Type: Review

References (103)

1. Lipschitz D. Physiologic changes with age. Cancer 1997. In press.
2. Lindeman RD. Overview: renal physiology and pathophysiology of aging. Am J Kidney Dis 1990;16:275-82.
3. Harrison DE. Proliferative capacity of erythropoietic stem cell lines and aging: an overview. Mech Ageing Dev 1979;9:409-26.
4. Harrison DE, Astle CM, Stone M. Numbers and functions of transplantable primitive immunohematopoietic stem cells: effects of age. J Immunol 1989;142:3833-40.
5. Miller RA. Aging and immune function. Int Rev Cytol 1991;124:187-209.
6. Dubrow EL. Reactivation of tuberculosis: a problem of aging. J Am Geriatr Soc 1976;24:481-7.
7. Nagami PH, Yoshikawa TT. Tuberculosis in the geriatric patient. J Am Geriatr Soc 1983;31:356-63.
8. Gelato MC. Aging and immune function: a possible role for growth hormone. Hormone Res 1996;45:46-9.
9. Arden NH, Patriaica PA, Kendal AP. Experiences in the use and efficacy of inactivated influenza vaccine in the nursing home. In: Kendal AP, Patriarca PA, editors. Options for the control of influenza. New York: Alan Liss, Inc., 1986;155-68.
10. Powers DC, Sears SD, Murphy BR, Thurmar B, Clements ML. Systemic and local antibody responses in elderly subjects give live or inactivated influenza A virus vaccines. J Clin Microbiol 1989;27:2666-71.
11. Kaesberg PR, Ershler WB. The importance of immune senescence in the incidence and malignant properties of cancer in hosts of advanced age. J Gerontol 1989;44:63-6.
12. Ershler WB, Stewart JA, Hacker MP, Moore AL, Tindle BA. B16 melanoma and aging: slower growth and longer survival in old mice. J Natl Cancer Inst 1984;72:161-4.
13. Ershler WB, Moore AL, Shore H, Gamelli RL. Transfer of age-associated restrained tumor growth in mice by old to young bone marrow transplantation. Cancer Res 1984;44:5677-80.
14. Stjernsward J. Age-dependent tumor host barrier and effect of carcinogen-induced immunodepression on rejection of isografted methylcholanthrene-induced sarcoma cells. J Natl Cancer Inst 1966;37:505-12.
15. Yuhas JM, Pazmino NH, Proctor JO, Toya RE. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor. Cancer Res 1974;34:722-8.
16. Rockwell SC. Effect of host age on transplantation, growth and radiation response of EMT6 tumors. Cancer Res 1981; 41:527-31.
17. Tsuda T, Kim YT, Siskind GW, et al. Role of the thymus and T cells in slow growth of B16 melanoma in old mice. Cancer Res 1987;47:3097-102.
18. Christensen K, Vaupel JW. Determinants of longevity: genetic, environmental and medical factors. J Intern Med 1996; 240:333-41.
19. Guyer B, Strobino DM, Ventura SJ, MacDorman M, Martin JA. Annual summary of vital statistics, 1995. Pediatrics 1996; 98:1007-19.
20. Greville TNE. U.S. life tables by cause of death, 1969-1971. U.S. Decennial Life Tables for 1969-1971 1971;1:5-15.
21. Riggs JE. Longitudinal Gompertzian analysis of adult mortality in the U.S., 1900-1986. Mech Ageing Dev 1990;54:235-47.
22. Hirsch HR. Can an improved environment cause maximum survival to decrease? comments on lifespan criteria and longitudinal Gompertzian analysis. Exp Gerontol 1994;29:119-37.
23. Orr WC, Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994;263:1128-30.
24. Weindruch R. Caloric restriction and aging. Sci Am 1996;274: 46-52.
25. Nakamura E, Lane MA, Roth GS, Ingram DK. Evaluating measures of hematology and blood chemistry in male rhesus monkeys as biomarkers of aging. Exp Gerontol 1994;29:151-77.
26. Kemnitz JW, Weindruch R, Roecker EB, Crawford K, Kaufman PL, Ershler WB. Dietary restriction of adult male rhesus monkeys: design, methodology, and preliminary findings from the first year of study. J Gerontol 1993;48:B17-26.
27. East J, Prosser PR. Autoimmunity and malignancy in New Zealand black mice. Proc R Soc Med 1967;60:823-5.
28. Weindruch R, Walford RL. Dietary restriction in mice beginning at 1 year of age. Science 1982;215:1415-8.
29. Pattengale PK, Taylor CR. Experimental models of lymphoproliferative disease: the mouse as a model for human non-Hodgkin's lymphomas and related leukemias. Am J Pathol 1983;113:237-65.
30. Weindruch R, Masoro EJ. Concerns about rodent models for aging research. J Gerontol 1991;3:B87-8.
31. Cristofalo VJ, Pignolo RJ. Replicative senescence of human fibroblast-like cells in culture. Physiol Rev 1993;73:617-38.
32. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-36.
33. Cristofalo VJ, Palazzo R, Charpentier RL. Limited lifespan of human fibroblasts in vitro: metabolic time or replications? In: Adelman RC, Roberts J, Baker GT, editors. Neural regulatory mechanisms during aging. New York: Alan R. Liss, Inc., 1980.
34. Schneider EL, Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci U S A 1976;73:3584-8.
35. Rohme D. Evidence for a relationship between longevity of mammalian species and life-spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci U S A 1976; 78:5009-13.
36. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995;92:9363-7.
37. Martin GM. The genetics of aging. Hosp Pract (Off Ed) 1997;32:47-50.
38. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, et al. Positional cloning of the Werner's syndrome gene. Science 1996;272:258-62.
39. Yu CE, Oshima J, Wijsman EM, Nakura J, Miki T, Piussan C, et al. Mutations in the consensus helicase domains of the Werner syndrome gene. Am J Genet 1997;60:330-41.
40. Kennedy BK, Guarente L. Genetic analysis of aging in Saccharomyces cerevisiae. Trends Genet 1996;12:355-9.
41. Szilard L. On the nature of the aging process. Proc Natl Acad Sci U S A 1959;45:30-5.
42. Morley AA. Is aging the result of dominant or co-dominant mutations? J Theor Biol 1982;98:469-74.
43. Cummings DJ. Mitochondrial DNA in Podopora anserina: a molecular approach to cellular senescence. Monogr Dev Biol 1984;17:254-66.
44. Fairweather S, Fox M, Margison BP. The in vitro lifespan of MRC-5 cells is shortened by 5-azacytidine-induced demethylation. Exp Cell Res 1987;168:153-8.
45. Burnet M. Intrinsic mutagenesis: a genetic approach for aging. New York: John Wiley & Sons, Inc., 1974.
46. Hart RW, Setlow RB. Correlation between deoxyribonucleic acid excision repair and lifespan in a number of mammalian species. Proc Natl Acad Sci U S A 1974;71:2169-73.
47. Orgel LE. The maintenance of the accuracy of protein synthesis and its relevance to aging. Proc Natl Acad Sci U S A 1963;49:517-21.
48. Allsop RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992; 89:10114-8.
49. Bjorksten J. Cross linkage and the aging process. In: Rothstein M, editor. Theoretical aspects of aging. New York: Academic Press, 1974:43.
50. Kohn RR. Aging of animals: possible mechanisms. In: Principles of mammalian aging. 2nd edition. Englewood Cliffs, NJ: Prentice-Hall, 1978.
51. Kreisle RA, Stehler B, Ershler WB. Effect of host age on tumor associated angiogenesis in mice. J Natl Cancer Inst 1990; 82:44-7.
52. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
53. Harman D. The aging process. Proc Natl Acad Sci U S A 1981;78:7124-8.
54. Sohal RS, Svensson I, Sohal BH, Brunk UT. Superoxide radical production in different animal species. Mech Ageing Dev 1989;49:129-35.
55. Sohal RS, Sohal BH, Brunk UT. Relationship between antioxidant defenses and longevity in different mammalian species. Mech Ageing Dev 1990;53:217-27.
56. Sohal RS, Allen RG. Oxidative stress as a causal factor in differentiation and aging: a unifying hypothesis. Exp Gerontol 1990;25:499-522.
57. Lee CM, Chung SS, Kaczkowski JM, Weindruch R, Aiken JM. Multiple mitochondrial DNA deletions associated with age in skeletal muscle of rhesus monkeys. J Gerontol 1993;48: B201-5.
58. Schwarze SR, Lee CM, Chung SS, Roecker EB, Weindruch R, Aiken J. High levels of mitochondrial DNA deletions in skeletal muscle of old rhesus monkeys. Mech Ageing Dev 1995;83: 91-101.
59. Melov S, Shoffner JM, Kaufman A, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucleic Acids Res 1995;23:4122-6.
60. Li Y, Huang YY, Carlson EJ, Melov S, Ursell PC, Olson JL, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese Superoxide dismutase. Nature 1995;11:376-81.
61. Sohal RS. Hydrogen peroxide production by mitochondria may be a biomarker of aging. Mech Ageing Dev 1991;60:189-98.
62. Epstein CJ, Avraham KB, Lovett M. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down's syndrome. Proc Natl Acad Sci U S A 1987;84:8044-8.
63. Harris TB, Roubenoff RR, Langlois J, Hannan M, Havlik R, Wilson P. Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: the Framingham Heart Study. J Am Geriatr Soc 1997;45:133-9.
64. Birkenhager-Gillesse EG, Derkson J, Lagaay AM. Dehydroepiandrosterone sulfate (DHEAS) in the oldest old, aged 85 and over. Ann N Y Acad Sci 1994;719:543-2.
65. Rudman D, Drinka PJ, Wilson CR, Scherman F, Cuisinier MC, Schults S. Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin Endocrinol 1994;40:653-61.
66. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6.
67. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. Testosterone administration increases insulin-like growth facto-1 levels in normal men. J Clin Endocrinol Metab 1993;77:776-9.
68. Walford R. The immunologic theory of aging. Copenhagen: Munksgard, 1969.
69. Makinodan T, Kay MMB. Age influence on the immune system. Adv Immunol 1980;29:287-330.
70. Smith GS, Walford RL. Influence of the main histocompatibility complex on aging in mice. Nature 1977;270:727-9.
71. Hirokawa K, Albright JW, Makinodan T. Restoration of impaired immune function in aging animals. I. Effect of syngeneic thymus and bone marrow grafts. Clin Immunol Immunopathol 1985;5:371-6.
72. Baker GT, Sprott RL. Biomarkers of aging. Exp Gerontol 1988;23:223-39.
73. Gatti RQ, Good RA. Aging, immunity and malignancy. Geriatrics 1979;25:158-68.
74. Bulychev W. Longevity, atherosclerosis and cellular immunity. Klin Med (Mosk) 1993;71:51-4.
75. Lehuen A, Bendelac A, Bach JF, Carnaud C. The nonobese diabetic mouse model: independent expression of humoral and cell mediated autoimmune features. J Immunol 1990; 144:2147-51.
76. Hull M, Strauss S, Berger M, Volk B, Bauer J. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain Res 1996; 78:37-41.
77. Hull M, Fiebich BL., Lieb S, Berger SS, Volk B, Bauer J. Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options. Neurobiol Aging 1996;17:795-800.
78. Gillis S, Kozak R, Durante M, Weksler ME. Decreased production and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest 1981;67:937-42.
79. Miller RA. The aging immune system: primer and prospectus. Science 1996;273:70-4.
80. Stephan RP, Sanders VM, Witte PL. Stage-specific alterations in murine lymphopoiesis with age. Int Immunol 1996;8: 509-18.
81. Radl I, Sepers JM, Skvaril F. Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol 1975;22:84-90.
82. Radl J. Animal model of human disease: benign monoclonal gammopathy (idiopathic paraproteinemia). Am J Pathol 1981;105:91-3.
83. Radl J. Age-related monoclonal gammopathies: clinical lessons from the aging C57BL/6 mouse. Immunol Today 1990;11:234-6.
84. Kyle RA. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma: implications for progression to overt myeloma. Hematol Oncol Clin North Am 1997;11:71-87.
85. Thoman M, Weigle WO. Lymphokines and aging: interleukin-2 production and activity in aged animals. J Immunol 1981;127:2102-6.
86. Ershler WB, Sun WH, Binkley N. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 1993;12:225-30.
87. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 1993;41:176-81.
88. Holmes F. Clinical evidence for a change in tumor aggressiveness with age. Semin Oncol 1989;16:34-40.
89. Prehn RT, Lappe MA. An immunostimulation theory of tumor development. Transplant Rev 1971;7:26-54.
90. Prehn RT. The immune reaction as a stimulator of tumor growth. Science 1972;176:170-1.
91. Finch CE, Landfield PW. Neuroendocrine and autonomic functions in aging mammals. In: Finch CE, Schneider, EL, editors. Handbook of the biology of aging. New York: Van Nostrand Reinhold, 1985:567.
92. Jiang D, Fei RG, Penergass WR, Wolf NS. An age-related reduction in the replicative capacity of two murine hematopoietic stroma cell types. Exp Hematol 1992;20:1216-22.
93. Sohal RS, Agarwal S, Dubey A, Orr WC. Protein oxidative damage is associated with life expectancy of houseflies. Proc Natl Acad Sci U S A 1993;90:7255-9.
94. Roth GS, Joseph JA. Age-related changes in transcriptional and posttranscriptional regulation of the dopaminergic system. Life Sci 1994;55:2031-5.
95. Franklin RA, Arkins S, Kelley KW. The proliferative response of rat T cells to calcium ionophores with age. Cell Immunol 1990;130:416-28.
96. Higgins BCA, Stout JT, Heller DA, Parker RF. Individual variability in tail tendon fiber break time in three age cohorts of different strains of mice. Exp Gerontol 1991;26:1467-77.
97. Bito LZ, De Rousseau CJ, Kaufman PL, Bito JW. Age-dependent loss of accommodative amplitude in rhesus monkeys: an animal model for presbyopia. Invest Ophthalmol Vis Sci 1982;23:23-31.
98. Williams DD, Short R, Bowden DM. Fingernail growth rate as a biomarker of aging in the pigtailed macaque (Macaca nemestrina). Exp Gerontol 1990;25:423-32.
99. Lane MA, Reznick AZ, Tilmont EM, Lanir, A, Ball SS, Read V, et al. Aging and food restriction alter some indices of bone metabolism in male rhesus monkeys (Macaca mulatta). J Nutr 1995;125:1600-10.
100. Weale R. Why does the human visual system age in the way it does? Exp Eye Res 1995;60:49-55.
101. Tamm S, Tamm E, Rohen JW. Age-related changes of the human ciliary muscle: a quantitative morphometric study. Mech Ageing Dev 1992;62:209-21.
102. Hartnell JM, Morley JE, Mooradian AD. Reduction of alkali-induced white blood cell DNA unwinding rate: a potential biomarker of aging. J Gerontol 1989;44:B125-30.
103. Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N (epsilon)-(carboxymethyl) lysine in human tissues in diabetes and aging. J Clin Invest 1997;99:457-68.